Axios reported that presidential trade adviser Peter Navarro heatedly confronted Dr. Anthony Fauci on Saturday over whether or not there has been “clear” evidence showing hydroxychloroquine’s effectiveness against COVID-19.

The fiery exchange did little to stifle President Trump’s praise of the drug, as he continued to push it in back-to-back press conferences this weekend.

On Sunday, Trump cut off a reporter trying to ask Dr. Fauci about his thoughts on hydroxychloroquine’s effectiveness.

Navarro Clashes With Fauci Over Hydroxychloroquine

The debate within the Trump Administration on how to advertise hydroxychloroquine as a treatment for COVID-19 heated up over the weekend in a fiery exchange between presidential trade adviser Peter Navarro and Dr. Anthony Fauci.

According to an exclusive report by Axios, that confrontation happened Saturday afternoon in the White House Situation Room. It began after Commissioner of Food and Drugs Stephen Hahn began talking about hydroxychloroquine, an anti-malarial drug that’s being investigated to possibly treat COVID-19 patients.

President Trump has frequently touted it at press conferences, calling it a “game-changer” for the United States. Many scientists like Dr. Fauci, however, have been more cautious on how to present the drug to the public since it’s not currently approved to treat COVID-19. This is because hydroxychloroquine has a number of known side effects, including heart and vision problems.

While their argument isn’t to necessarily prevent hydroxychloroquine from ever being used, scientists simply want to make sure the benefits outweigh the risks before it gets widespread use.

In the meeting, Hahn reportedly started giving updates regarding different hydroxychloroquine trials.

Navarro then got up, and according to an Axios source familiar with the situation, “…the first words out of his mouth are that the studies that he’s seen, I believe they’re mostly overseas, show ‘clear therapeutic efficacy.’ Those are the exact words out of his mouth.”

Fauci then pushed back, saying that at the moment, the evidence for those studies and hydroxychloroquine’s effectiveness is only anecdotal. Notably, that is something he’s repeatedly said in the past weeks.

Fauci’s comment reportedly set Navarro off. According to Axios’ sources, Navarro then pointed to those studies and said, “That’s science, not anecdote.”

Reportedly, he then started yelling and accused Dr. Fauci of objecting to Trump’s travel restrictions, saying, “You were the one who early on objected to the travel restrictions with China.”

Dr. Fauci and others then reportedly looked confused, likely because Fauci has praised Trump’s travel restrictions on China.

Following that, Vice President Mike Pence and others reportedly tried to moderate the discussion, a source saying, “It was pretty clear that everyone was just trying to get [Navarro] to sit down and stop being so confrontational.”

Eventually, Jared Kushner reportedly managed to convince Navarro and everyone else to change the conversation to hot zones in the U.S.

Before they did, they agreed that the administration’s stance should be that the decision to use the drug is between patients and doctors prescribing it off-label.

“There has never been a confrontation in the task force meetings like the one yesterday,” Axios’ sources said. “People speak up and there’s robust debate, but there’s never been a confrontation. Yesterday was the first confrontation.”

Monday morning, Navarro spoke on that disagreement and defended himself on CNN, saying, “Doctors disagree about things all the time. My qualifications in terms of looking at the science is that I’m a social scientist. I have a Ph. D. And I understand how to read statistical studies, whether it’s in medicine, the law, economics or whatever.”

Trump Continues to Tout Hydroxychloroquine

Despite a notable escalation in tensions over hydroxychloroquine among President Doanld Trump’s advisers, it did not seem to stop Trump from propping up the drug this weekend.

“What do you have to lose?” Trump said Saturday. “It’s been out there for a long time, and I hope they use it. And they’re going to look at the—with doctors, work with doctors, get what you have to get.

“And I hope they use it because it’s been used for a long time and therefore, it’s passed the safety tests,” he continued.

“In fact, I might do it anyway,” Trump added on hydroxychloroquine. “I may take it. I’ll have to ask my doctors about that, but I may take it.”

Alongside that, Trump said that the U.S. has stockpiled 29 million pills of hydroxychloroquine.

Trump continued to rush hydroxychloroquine as a treatment on Sunday, saying, “We don’t have time to say, ‘Gee, let’s go and take a couple of years and test it out. And let’s go and test with the test tubes and the laboratories.’ We don’t have time. I’d love to do that, but we have people dying today, as we speak, there are people dying.”

Sunday’s press briefing, however, was eclipsed by another moment when Trump cut off a reporter as that reporter tried to ask Dr. Fauci a question regarding his opinion on the use of hydroxychloroquine.

“Would you also weigh in on this issue of hydroxychloroquine? What do you think about this and what is the medical evidence?” a reporter asked Fauci, who was taking questions from the podium

“Do you know how many times he’s answered that question?” Trump asked, stepping forward from the side as Dr. Fauci “Maybe fifteen. Fifteen times. You don’t have to ask the question.”

“The question is for the doctor,” the reporter said. “He’s your medical expert, correct?”

“He’s answered that question 15 times,” Trump repeated before moving onto the next question.

Where Is the U.S. With Hydroxychloroquine?

Right now, the United States is likely still months away from knowing whether or not hydroxychloroquine will prove to be effective against COVID-19.

That said, clinical trials have already begun in New York. Last week, the Food and Drug Administration also approved hydroxychloroquine for emergency treatment.

On Sunday, Pence announced another clinical trial, a 3,000 person trial set to begin with the Henry Ford Health System in Detroit. Specifically, it will look at whether or not hydroxychloroquine will prevent COVID-19 in healthcare workers battling the virus.

“This is going to be the first major, definitive study in healthcare workers and first responders of hydroxychloroquine as a preventative medication,” said Dr. William O’Neill with the Henry Ford Health System. “There has been a lot of talk about this drug, but only a small, non-blinded study in Europe. We are going to change that in Metro Detroit and produce a scientific answer to the question: Does it work?”

Still, that study will also take at least a few months to conduct. Even then, doctors are warning that timely caution is the best practice for this drug.

“There could be negative side effects,” President of the American Medical Association Dr. Patrice Harris said on CNN. “There could be deaths. This is a new virus, and so we should not be promoting any medication or drug for any disease that has not been proven and approved by the FDA.”

“You could lose your life,” she added after being asked about potential dangers. “It’s unproven. And so certainly there are some limited studies, as Dr. Fauci said. But at this point, we just don’t have the data to suggest that we should be using this medication for COVID-19.”

Se what others are saying: (Axios) (CNN) (Newsweek)